Illumina's Low-Cost MiSeq Promises to Speed up Next-Gen Sequencing | GenomeWeb

By Julia Karow

This article, originally published Jan. 11, has been updated with additional information from Illumina's presentation at the JP Morgan Healthcare Conference and from the company's website.

Illumina last week announced a new low-cost sequencing platform called MiSeq, which promises to go from purified DNA to analyzed data in as few as eight hours, and to generate more than a gigabase of sequence in slightly more than a day of total experimental time.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.